Cataract

The Visiometrics HD Analyzer – for more personalized procedure selection and higher patient satisfaction

Anti-inflammatories that reduce patient adherence or offer a more reliable delivery mechanism are driving the evolution of postoperative regimens

Bausch + Lomb reflects on a legacy of ophthalmic excellence – from the enVista® IOL platform to the Vitesse™ hypersonic vitrectomy system, and beyond

Digital twin technology is enabling patient-specific surgery planning for optimal refractive outcomes

Software that models the eye and simulates surgery on a digital twin is revolutionizing cataract treatment

Restoring vision using a smart, active intraocular lens for cataract surgery

Jason Bacharach on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

Mark Pyfer on the first — and only — FDA-approved intraocular steroid for postoperative inflammation

The RCOphth National Ophthalmology Database (NOD) Audit can provide richer outcomes analysis than any single individual or institution – and cost less

Michael Savetsky on the first — and only — FDA-approved intraocular steroid for postoperative inflammation